Preformed cytotoxic antibodies in potential allograft recipients: recent data.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Human Immunology

• Publication date

  2005-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.HUMIMM.2005.01.030PMID 15866696
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Maintenance of serum antibody levels.

  2005cited by this paper
• De novo production of antibodies after heart or lung transplantation should be regarded as an early warning system.

  2004cited by this paper
• Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells.

  2004cited by this paper
• Pre‐exposure to sub‐saturating concentrations of HLA class I antibodies confers resistance to endothelial cells against antibody complement‐mediated lysis by regulating Bad through the phosphatidylinositol 3‐kinase/Akt pathway

  2004cited by this paper
• Accommodation: Preventing Injury in Transplantation and Disease1

  2004cited by this paper
• Risk Factors for Capillary C4d Deposition in Kidney Allografts: Evaluation of a Large Study Cohort

  2004cited by this paper
• Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial.

  2004cited by this paper
• A clinicopathologic study of isolated intestinal allografts with preformed IgG lymphocytotoxic antibodies.

  2004cited by this paper
• National Conference to Assess Antibody‐Mediated Rejection in Solid Organ Transplantation

  2004cited by this paper
• Non‐HLA‐Type Endothelial Cell Reactive Alloantibodies in Pre‐Transplant Sera of Kidney Recipients Trigger Apoptosis

  2003cited by this paper
• Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities

  2003cited by this paper
• Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation

  2003cited by this paper
• Pancreas transplantation in crossmatch‐positive recipients

  2003cited by this paper
• Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease.

  2003cited by this paper
• Role of the complement system in rejection.

  2003cited by this paper
• Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients

  2003cited by this paper
• Pre‐Transplant Assessment of Donor‐Reactive, HLA‐Specific Antibodies in Renal Transplantation: Contraindication vs. Risk

  2003cited by this paper
• Signal transduction via MHC class I molecules in endothelial and smooth muscle cells.

  2003cited by this paper
• Humoral rejection of human organ transplants

  2003cited by this paper
• Maintenance of Serological Memory by Polyclonal Activation of Human Memory B Cells

  2002cited by this paper
• A clinicopathologic study of isolated intestinal allografts with preformed IgG lymphocytotoxic antibodies.

  2002cited by this paper
• Humoral rejection in kidney transplantation: new concepts in diagnosis and treatment

  2002cited by this paper
• Transplant Accommodation in Highly Sensitized Patients: A Potential Role for Bcl‐xL and Alloantibody

  2001cited by this paper
• HYPERACUTE REJECTION IN SINGLE LUNG TRANSPLANTATION—CASE REPORT OF SUCCESSFUL MANAGEMENT BY MEANS OF PLASMAPHERESIS AND ANTITHYMOCYTE GLOBULIN TREATMENT

  2001cited by this paper
• Susceptibility of Liver Allografts to High or Low Concentrations of Preformed Antibodies as Measured by Flow Cytometry

  2001cited by this paper
• Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection.

  2000cited by this paper
• PLASMAPHERESIS AND INTRAVENOUS IMMUNE GLOBULIN PROVIDES EFFECTIVE RESCUE THERAPY FOR REFRACTORY HUMORAL REJECTION AND ALLOWS KIDNEYS TO BE SUCCESSFULLY TRANSPLANTED INTO CROSS-MATCH-POSITIVE RECIPIENTS

  2000cited by this paper
• The impact of HLA sensitization and donor cause of death in heart transplantation.

  2000cited by this paper
• Twelve years' experience with national sharing of HLA-matched cadaveric kidneys for transplantation.

  2000cited by this paper
• Simultaneous HLA Class I and Class II antibodies screening with flow cytometry.

  1998cited by this paper
• Comparison of PRA-STAT, sHLA-EIA, and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients: correlation to rejection and posttransplantation coronary artery disease.

  1998cited by this paper
• Cross-matching in liver transplantation.

  1997cited by this paper
• Hyperacute rejection following lung transplantation.

  1996cited by this paper
• The flow cytometric crossmatch in liver transplantation.

  1995cited by this paper
• THE RELATIONSHIP AMONG DONOR‐RECIPIENT HLA MISMATCHES, REJECTION, AND DEATH FROM CORONARY ARTERY DISEASE IN CARDIAC TRANSPLANT RECIPIENTS1

  1994cited by this paper
• High one‐month liver graft failure rates in flow cytometry crossmatch‐positive recipients

  1994cited by this paper
• Anti-idiotypic antibodies specific for HLA in heart and kidney allograft recipients

  1993cited by this paper
• SUPPRESSION OF HLA‐SPECIFIC ALLOANTIBODIES BY HIGH‐DOSE INTRAVENOUS IMMUNOGLOBULINS (IVIg): A POTENTIAL TOOL FOR TRANSPLANTATION OF IMMUNIZED PATIENTS

  1993cited by this paper
• Hyperacute and acute kidney graft rejection due to antibodies against B cells.

  1992cited by this paper
• Influence of panel-reactive antibody and lymphocytotoxic crossmatch on survival after heart transplantation.

  1991cited by this paper
• Characterization of lymphocytotoxic antibodies causing a positive crossmatch in renal transplantation. Relationship to primary and regraft outcome.

  1989cited by this paper
• Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma.

  1989cited by this paper
• Successful transplants across T warm‐positive crossmatches due to IgM antibodies

  1988cited by this paper
• Effect of antiidiotypic antibodies to HLA on graft survival in renal-allograft recipients.

  1987cited by this paper
• Improvement of kidney transplant regraft results by using trauma death donors.

  1987cited by this paper
• IMPROVEMENT OF KIDNEY TRANSPLANT REGRAFT RESULTS BY USING TRAUMA DEATH DONORS

  1987cited by this paper
• DONOR‐SPECIFIC B AND T LYMPHOCYTE ANTIBODIES AND KIDNEY GRAFT SURVIVAL

  1981cited by this paper
• B cell antibodies and crossmatching.

  1980cited by this paper
• Improved survival and function of renal transplants with positive B cell crossmatches.

  1979cited by this paper
• Long-term cadaver allograft survival in the recipient with a positive B lymphocyte crossmatch.

  1979cited by this paper
• KIDNEY TRANSPLANTATION ACROSS POSITIVE B AND T CELL CROSSMATCHES

  1978cited by this paper
• REACTIVITY OF AUTOLYMPHOCYTOTOXIC ANTIBODIES FROM DIALYSIS PATIENTS WITH LYMPHOCYTES FROM CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS

  1978cited by this paper
• Renal transplantation and B-cell cross-matches with autoantibodies and alloantibodies.

  1977cited by this paper
• IMPORTANCE OF THE AUTOCONTROL CROSSMATCH IN HUMAN RENAL TRANSPLANTATION

  1976cited by this paper
• Significance of the positive crossmatch test in kidney transplantation.

  1969cited by this paper

• Anti-Human Leukocyte Antigen Antibody Detection from Terasaki’s Humoral Theory to Delisting Strategies in 2024

  2025cites this paper
• Impact of random amplified polymorphic DNA analysis as a genetic crossmatching tool for human kidney transplantation.

  2025cites this paper
• Luminex Multiplex Bead Assay Monitoring HLA IgG Antibodies in Sensitized Pre- and Post-transplant Patients: Clonality of the Detection Antibody Impacts Specificity and Sensitivity

  2021cites this paper
• The results of HLA‐incompatible kidney transplantation according to pre‐transplant crossmatch tests: Donor‐specific antibody as a prominent predictor of acute rejection

  2019cites this paper
• Impact of pretransplant donor‐specific antibodies on kidney allograft recipients with negative flow cytometry cross‐matches

  2018cites this paper
• Dual‐Donor Organ Exchange

  2017cites this paper
• HLA Class Ia and Ib Polyreactive Anti-HLA-E IgG2a Monoclonal Antibodies (TFL-006 and TFL-007) Suppress Anti-HLA IgG Production by CD19+ B Cells and Proliferation of CD4+ T Cells While Upregulating Tregs

  2017cites this paper
• Alemtuzumab Equalizes Short Term Outcomes in High Risk PRA Patients: Long Term Outcomes Suffer

  2017cites this paper
• Detection of donor-specific-antibodies by solid phase assay and its relevance to complement-dependent-lymphocytotoxicity cross-matching in kidney transplantation.

  2014cites this paper
• Clinical impact of H-Y alloimmunity

  2014cites this paper
• Transplantation in highly HLA-sensitized patients: challenges and solutions

  2014cites this paper
• Methodological aspects of anti-human leukocyte antigen antibody analysis in solid organ transplantation.

  2014cites this paper
• Establishment of a flow cytometric assay in the setting of renal transplant for T and B cell crossmatching

  2014cites this paper
• Modified solid-phase alloantibody detection for improved crossmatch prediction.

  2013cites this paper
• Detection of presensitization in recipients of kidney transplants

  2013cites this paper
• Role of human leukocyte antigen, donor-specific antibodies, and their impact in renal transplantation.

  2012cites this paper
• The clinical significance of human leukocyte antigen antibody development in kidney transplantation.

  2012cites this paper
• Preformed and De Novo Donor Specific Antibodies in Visceral Transplantation: Long‐Term Outcome With Special Reference to the Liver

  2012cites this paper
• Desensitization and crossmatch conversion in deceased donor kidney transplantation.

  2011cites this paper
• Rapamycin-induced Allograft Tolerance: Elucidating Mechanisms and Biomarker Discovery

  2011cites this paper
• INMUNIDAD HUMORAL Y TRASPLANTE RENAL POSIBILIDADES TERAPÉUTICAS HUMORAL INMUNITY AND RENAL TRASPLANT. THERAPEUTIC POSSIBILITIES

  2010cites this paper
• Inmunidad humoral y trasplante renal posibilidades terapéuticas

  2010cites this paper
• Differential effects of donor-specific alloantibody.

  2009cites this paper
• Living donor renal transplantation in the presence of donor-specific human leukocyte antigen antibody detected by solid-phase assay.

  2009cites this paper
• Clinical relevance of preformed C4d‐fixing and non‐C4d‐fixing HLA single antigen reactivity in renal allograft recipients

  2009cites this paper
• Eighteen-year follow-up of a retrospective study of HLA antibody on kidney graft survival.

  2009cites this paper
• Detection of Immunoglobulin G Human Leukocyte Antigen-Specific Alloantibodies in Renal Transplant Patients Using Single-Antigen-Beads is Compromised by the Presence of Immunoglobulin M Human Leukocyte Antigen-Specific Alloantibodies

  2009cites this paper
• Relevance of MICA and other non-HLA antibodies in clinical transplantation.

  2008cites this paper
• Tailoring Antibody Testing and How to Use it in the Calculated Panel Reactive Antibody Era: The Northwestern University Experience

  2008cites this paper
• Antibodies, isotypes and complement in allograft rejection.

  2008cites this paper
• Four Stages and Lack of Stable Accommodation in Chronic Alloantibody‐Mediated Renal Allograft Rejection in Cynomolgus Monkeys

  2008cites this paper
• Beyond ABO and human histocompatibility antigen: other histocompatibility antigens with a role in transplantation.

  2008cites this paper
• Acceptable Donor-Specific Antibody Levels Allowing for Successful Deceased and Living Donor Kidney Transplantation After Desensitization Therapy

  2008cites this paper
• The problem of transplanting the sensitized patient: whose problem is it?

  2008influential citation
• Preoperative treatment of a presensitized kidney transplant recipient with donor‐derived transplant acceptance‐inducing cells

  2008cites this paper
• Early and late humoral rejection: a clinicopathologic entity in two times.

  2008cites this paper
• Vision improvement in retinal degeneration patients by implantation of retina together with retinal pigment epithelium.

  2008cites this paper
• Does flow cytometry crossmatch predict renal allograft outcome in patients with a negative antiglobulin crossmatch?

  2007cites this paper
• Histocompatibility testing for highly sensitized transplant candidates.

  2007cites this paper
• Significance of histocompatibility in organ transplantation

  2007cites this paper
• Acute Antibody‐Mediated Rejection Following Heart Transplantation

  2007cites this paper
• Determinants of the Complement-Fixing Ability of Recipient Presensitization Against HLA Antigens

  2007cites this paper
• HLA-Specific B Cells: II. Application to Transplantation

  2007cites this paper
• Renal Transplantation in Patients With Pre‐Transplant Donor‐Specific Antibodies and Negative Flow Cytometry Crossmatches

  2007cites this paper
• HLA Class II‐Like Antiidiotypic Antibodies from Highly Sensitized Patients Inhibit T‐Cell Alloresponses

  2007cites this paper
• HLA-Specific B Cells: I. A Method for Their Detection, Quantification, and Isolation Using HLA Tetramers

  2007cites this paper
• Pivotal Role of Complement‐Fixing HLA Alloantibodies in Presensitized Kidney Allograft Recipients

  2006cites this paper
• Prolonged cardiac allograft survival in presensitized rats after a high activity Yunnan-cobra venom factor therapy.

  2006cites this paper
• [ABO-incompatible renal transplantation].

  2006cites this paper
• Transplantation rénale ABO incompatible

  2006cites this paper
• Prediction of Crossmatch Outcome of Highly Sensitized Patients by Single and/or Multiple Antigen Bead Luminex Assay

  2006cites this paper
• Diagnostic value of C4d in renal biopsies

  2005cites this paper